Journal of the Neurological Sciences
Volume 288, Issue 1 , Pages 63-67 , 15 January 2010

Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort

  • Jing-Shan Wu

      Affiliations

    • Australian Neuromuscular Research Institute, Sir Charles Gairdner Hospital; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Queen Elizabeth II Medical Centre, 6009, Perth, WA, Australia
    • ,
  • Wei Qiu

      Affiliations

    • Australian Neuromuscular Research Institute, Sir Charles Gairdner Hospital; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Queen Elizabeth II Medical Centre, 6009, Perth, WA, Australia
    • Department of Neurology, the Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, China
    • ,
  • Alison Castley

      Affiliations

    • Department of Clinical Immunology and Immunogenetics, PathWest Royal Perth Hospital, Perth, Western Australia, Australia
    • ,
  • Ian James

      Affiliations

    • Centre for Clinical Immunology & Biomedical Statistics, Murdoch University & Royal Perth Hospital, Perth, Western Australia, Australia
    • ,
  • Joyce Joseph

      Affiliations

    • Australian Neuromuscular Research Institute, Sir Charles Gairdner Hospital; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Queen Elizabeth II Medical Centre, 6009, Perth, WA, Australia
    • ,
  • Frank T Christiansen

      Affiliations

    • Department of Clinical Immunology and Immunogenetics, PathWest Royal Perth Hospital, Perth, Western Australia, Australia
    • School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Western Australia, Australia
    • ,
  • William M Carroll

      Affiliations

    • Australian Neuromuscular Research Institute, Sir Charles Gairdner Hospital; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Queen Elizabeth II Medical Centre, 6009, Perth, WA, Australia
    • ,
  • Frank L Mastaglia

      Affiliations

    • Australian Neuromuscular Research Institute, Sir Charles Gairdner Hospital; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Queen Elizabeth II Medical Centre, 6009, Perth, WA, Australia
    • ,
  • Allan G Kermode

      Affiliations

    • Australian Neuromuscular Research Institute, Sir Charles Gairdner Hospital; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Queen Elizabeth II Medical Centre, 6009, Perth, WA, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 8 93881865; fax: +61 8 93882149.

Received 27 July 2009 ,Revised 5 October 2009 ,Accepted 7 October 2009.

References 

  1. Villar LM, Masterman T, Casanova B, et al. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis. J Neuroimmunol. 2009;211(1–2):101–104
  2. Andersson M, Alvarez-Cermeno J, Bernardi G, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry. 1994;57(8):897–902
  3. Link H, Huang YM. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol. 2006;180(1–2):17–28
  4. Owens GP, Bennett JL, Lassmann H, et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol. 2009;65(6):639–649
  5. Lincoln MR, Montpetit A, Cader MZ, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet. 2005;37(10):1108–1112
  6. Hafler DA, Compston A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357(9):851–862
  7. Sellebjerg F, Jensen J, Madsen HO, et al. HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis. Tissue Antigens. 2000;55(4):312–318
  8. Imrell K, Landtblom AM, Hillert J, et al. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology. 2006;67(6):1062–1064
  9. Kikuchi S, Fukazawa T, Niino M, et al. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen. Neurology. 2003;60(4):647–651
  10. Oksenberg JR, Baranzini SE, Sawcer S, et al. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet. 2008;9(7):516–526
  11. Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet. 2006;15(18):2813–2824
  12. DeLuca GC, Ramagopalan SV, Herrera BM, et al. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc Natl Acad Sci U S A. 2007;104(52):20896–20901
  13. Wu JS, Zhang MN, Carroll WM, et al. Characterisation of the spectrum of demyelinating disease in Western Australia. J Neurol Neurosurg Psychiatry. 2008;79(9):1022–1026
  14. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology. 1983;13(3):227–231
  15. Compston A, Edan G, Goodkin D, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology. 2001;50(1):121–127
  16. Welborn TA. The Besselton study: mapping population health. In: Cardiovascular and respiratory disease risk factors in Busselton, Australia. Sydney: Australasian Medical Publishing Company; 1998;
  17. Sayer D, Whidborne R, Brestovac B, et al. HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. Tissue Antigens. 2001;57(1):46–54
  18. Walker RW, Keir G, Johnson MH, et al. A rapid method for detecting oligoclonal IgG in unconcentrated CSF, by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining. J Neuroimmunol. 1983;4(2):141–148
  19. Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005;62(6):865–870
  20. Stankovich J, Butzkueven H, Marriott M, et al. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens. 2009;74(1):17–21
  21. Wu JS, Qiu W, Castley JP, et al. Frequency of HLA-DRB1 alleles and disease-modifying effects in a large West Australian multiple sclerosis cohort. J Neurology. 2009;256:S158
  22. Idiman E, Ozakbas S, Dogan Y, et al. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds. J Neuroimmunol. 2009;212(1-2):121–124
  23. Obermeier B, Mentele R, Malotka J, et al. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med. 2008;14(6):688–693
  24. Tintore M, Rovira A, Rio J, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?. Neurology. 2008;70(13 Pt 2):1079–1083

PII: S0022-510X(09)00901-0

doi: 10.1016/j.jns.2009.10.005

Journal of the Neurological Sciences
Volume 288, Issue 1 , Pages 63-67 , 15 January 2010

Article Tools

* Image Usage & Resolution